News on diagnostics for respiratory pathogens, including influenza, coronavirus, and more.
The drug developer said that the biomarker panel will form the basis of a planned point-of-care test for acute respiratory distress syndrome.
Stakeholders discussed last year's decision by Palmetto to deny coverage for large respiratory panels and discussed the way forward for test developers and labs.
Flu test sales were the second-highest for a quarter in the firm's history but were still $17.4 million lower than the year-ago quarter due to a much less intense flu season.
Filamentous prophages turned up in a significant proportion of cystic fibrosis Pseudomonas aeruginosa lung infections, particular in older patients and drug-resistant cases.
The two genome-wide association studies of chronic obstructive pulmonary disease uncovered numerous novel risk variants, including ones in genes involved in ciliogenesis and lung development.
